NM_004208.4:c.1388G>T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PM1PP3_ModerateBS2

The NM_004208.4(AIFM1):​c.1388G>T​(p.Arg463Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000226 in 1,209,022 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 73 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00011 ( 0 hom., 3 hem., cov: 21)
Exomes 𝑓: 0.00024 ( 0 hom. 70 hem. )

Consequence

AIFM1
NM_004208.4 missense

Scores

10
5
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2B:2

Conservation

PhyloP100: 7.56

Publications

4 publications found
Variant links:
Genes affected
AIFM1 (HGNC:8768): (apoptosis inducing factor mitochondria associated 1) This gene encodes a flavoprotein essential for nuclear disassembly in apoptotic cells, and it is found in the mitochondrial intermembrane space in healthy cells. Induction of apoptosis results in the translocation of this protein to the nucleus where it affects chromosome condensation and fragmentation. In addition, this gene product induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Mutations in this gene cause combined oxidative phosphorylation deficiency 6 (COXPD6), a severe mitochondrial encephalomyopathy, as well as Cowchock syndrome, also known as X-linked recessive Charcot-Marie-Tooth disease-4 (CMTX-4), a disorder resulting in neuropathy, and axonal and motor-sensory defects with deafness and cognitive disability. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome 10. [provided by RefSeq, Aug 2015]
RAB33A (HGNC:9773): (RAB33A, member RAS oncogene family) The protein encoded by this gene belongs to the small GTPase superfamily, Rab family. It is GTP-binding protein and may be involved in vesicle transport. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_004208.4
PP3
MetaRNN computational evidence supports a deleterious effect, 0.87
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AIFM1NM_004208.4 linkc.1388G>T p.Arg463Ile missense_variant Exon 13 of 16 ENST00000287295.8 NP_004199.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AIFM1ENST00000287295.8 linkc.1388G>T p.Arg463Ile missense_variant Exon 13 of 16 1 NM_004208.4 ENSP00000287295.3 O95831-1
AIFM1ENST00000675092.1 linkc.1388G>T p.Arg463Ile missense_variant Exon 13 of 16 ENSP00000501772.1 A0A6Q8PFE1

Frequencies

GnomAD3 genomes
AF:
0.000108
AC:
12
AN:
110912
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000340
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000170
Gnomad OTH
AF:
0.000679
GnomAD2 exomes
AF:
0.000185
AC:
34
AN:
183468
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000312
Gnomad NFE exome
AF:
0.000269
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000238
AC:
261
AN:
1098110
Hom.:
0
Cov.:
31
AF XY:
0.000193
AC XY:
70
AN XY:
363466
show subpopulations
African (AFR)
AF:
0.0000379
AC:
1
AN:
26402
American (AMR)
AF:
0.000199
AC:
7
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19384
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54148
European-Finnish (FIN)
AF:
0.000716
AC:
29
AN:
40531
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.000257
AC:
216
AN:
842004
Other (OTH)
AF:
0.000174
AC:
8
AN:
46094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000108
AC:
12
AN:
110912
Hom.:
0
Cov.:
21
AF XY:
0.0000906
AC XY:
3
AN XY:
33098
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30488
American (AMR)
AF:
0.00
AC:
0
AN:
10351
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3551
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2607
European-Finnish (FIN)
AF:
0.000340
AC:
2
AN:
5879
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.000170
AC:
9
AN:
52995
Other (OTH)
AF:
0.000679
AC:
1
AN:
1472
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000186
Hom.:
6
Bravo
AF:
0.000136
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000346
AC:
1
ExAC
AF:
0.000157
AC:
19
EpiCase
AF:
0.000327
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tip-toe gait Pathogenic:1
Mar 12, 2021
Practice for Gait Abnormalities, David Pomarino, Competency Network Toe Walking c/o Practice Pomarino
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

Hereditary motor sensory neuropathy (HMSN), also known as Charcot-Marie-Tooth Disease (CMT), is the most commonly inherited peripheral polyneuropathy. It constitutes a group of inherited, progressive, motor and sensory peripheral nerve disorders with properties of demyelination, axonal degeneration, or both. It is classified by clinical characteristics, modes of inheritance, electrophysiologic features, metabolic defects, and specific gene markers. Our patients all walk on tiptoe, so they show similar symptoms. When we genetically test them with our toe walking panel, we find that around 90 per cent of them have a genetic variant that explains their toe walking. These can be assigned, for example, to the area of myopathies (such as variants of the COL6A3 gene), the area of hereditary neuropathies (such as variants of the KMT2C gene) or the area of metabolic diseases (such as variants of the PYGM gene). In a smaller group of patients with almost identical symptoms, no abnormality is found in the genes of our panel, but spastic paraplegia can be detected. In another small group of our toe walkers, no abnormalities can be detected in the genes analysed in our toe walking panel, nor do they suffer from spastic paraplegia, as is also the case with healthy children. In contrast to these, however, they show a tiptoe gait. These patients suffer from infantile cerebral palsy, in which toe walking can also be observed. -

Charcot-Marie-Tooth disease X-linked recessive 4 Pathogenic:1
Aug 18, 2015
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:research

Likely pathogenic based on conservation and prediction scores (Phylop, Polyphen, SIFT, MutationTaster) and consistent with neuropathy of patient. Patient also had Sotos syndrome with de novo frameshift insertion in NSD1 -

not provided Benign:1
Jan 08, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 26257172, 32376792) -

Combined oxidative phosphorylation deficiency;CN118851:Charcot-Marie-Tooth Neuropathy X Benign:1
Dec 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.28
D
BayesDel_noAF
Pathogenic
0.46
CADD
Pathogenic
29
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T;.;.;D
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
1.0
D;D;D;D
M_CAP
Pathogenic
0.49
D
MetaRNN
Pathogenic
0.87
D;D;D;D
MetaSVM
Uncertain
0.40
D
MutationAssessor
Uncertain
2.8
.;.;.;M
PhyloP100
7.6
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-7.9
D;D;D;D
REVEL
Uncertain
0.62
Sift
Uncertain
0.0010
D;D;D;D
Sift4G
Pathogenic
0.0010
D;D;D;D
Polyphen
0.93, 0.75, 0.33
.;P;P;B
Vest4
0.95
MVP
0.97
MPC
1.4
ClinPred
0.50
D
GERP RS
5.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.98
gMVP
0.99
Mutation Taster
=12/88
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.21
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.21
Position offset: 11

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202219398; hg19: chrX-129267348; API